Effect of starch malabsorption on fecal bile acids and neutral sterols in humans: possible implications for colonic carcinogenesis - PubMed (original) (raw)
Clinical Trial
. 1991 Aug 15;51(16):4238-42.
Affiliations
- PMID: 1868444
Clinical Trial
Effect of starch malabsorption on fecal bile acids and neutral sterols in humans: possible implications for colonic carcinogenesis
H P Bartram et al. Cancer Res. 1991.
Abstract
Epidemiological and experimental studies indicate a strong association between an elevated colon cancer risk and increased fecal excretion of secondary bile acids, neutral sterols, and prolonged gastrointestinal transit time. Starch malabsorption, on the other hand, has been reported to be a possible protective factor in colon carcinogenesis. To study the impact of starch malabsorption on these parameters, 12 healthy volunteers consumed a diet rich in starch for two 4-week periods. During a double-blind crossover trial they received the alpha-glucosidase inhibitor acarbose (BAY g 5421) in one of the study periods and placebo in the other. During acarbose treatment stool wet weight increased by 68%, stool dry weight by 57%, and gastrointestinal mean transit time by 30%. Fecal concentrations (mg/g dry weight) of the neutral sterols coprostanol, coprostanone, campesterol, 4-cholesten-3-one, and beta-sitosterol decreased by 36.8, 48.7, 42.1, 34.6, and 39.4%, respectively, under acarbose. Concentrations of the major secondary bile acids, deoxycholic and lithocholic acid, decreased by 59.9 and 52.2%, respectively. In spite of an increased stool weight, also daily excretion (mg/day) of these two bile acids was lower under acarbose (47.9 and 36.6%, respectively) compared to placebo, whereas excretion of the main primary bile acid, cholic acid, rose from 22.58 mg/day to 379.80 mg/day during the acarbose period. The changes in fecal bile acid and neutral sterol excretion found during acarbose treatment may explain a protective effect of starch malabsorption on colon cancer development.
Similar articles
- Effect of starch malabsorption on colonic function and metabolism in humans.
Scheppach W, Fabian C, Ahrens F, Spengler M, Kasper H. Scheppach W, et al. Gastroenterology. 1988 Dec;95(6):1549-55. doi: 10.1016/s0016-5085(88)80076-3. Gastroenterology. 1988. PMID: 3053313 Clinical Trial. - Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention.
Hylla S, Gostner A, Dusel G, Anger H, Bartram HP, Christl SU, Kasper H, Scheppach W. Hylla S, et al. Am J Clin Nutr. 1998 Jan;67(1):136-42. doi: 10.1093/ajcn/67.1.136. Am J Clin Nutr. 1998. PMID: 9440388 Clinical Trial. - The effect of starch malabsorption on fecal short-chain fatty acid excretion in man.
Scheppach W, Fabian C, Sachs M, Kasper H. Scheppach W, et al. Scand J Gastroenterol. 1988 Aug;23(6):755-9. doi: 10.3109/00365528809093945. Scand J Gastroenterol. 1988. PMID: 3175536 Clinical Trial. - Safety profile of acarbose, an alpha-glucosidase inhibitor.
Hollander P. Hollander P. Drugs. 1992;44 Suppl 3:47-53. doi: 10.2165/00003495-199200443-00007. Drugs. 1992. PMID: 1280577 Review. - Bile acids as carcinogens in the colon and at other sites in the gastrointestinal system.
Bernstein H, Bernstein C. Bernstein H, et al. Exp Biol Med (Maywood). 2023 Jan;248(1):79-89. doi: 10.1177/15353702221131858. Epub 2022 Nov 19. Exp Biol Med (Maywood). 2023. PMID: 36408538 Free PMC article. Review.
Cited by
- Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice.
Kato J, Shirakami Y, Mizutani T, Kubota M, Sakai H, Ibuka T, Shimizu M. Kato J, et al. Int J Mol Sci. 2020 Mar 23;21(6):2226. doi: 10.3390/ijms21062226. Int J Mol Sci. 2020. PMID: 32210144 Free PMC article. - Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial.
Iijima T, Aoki K, Kondo Y, Terauchi Y. Iijima T, et al. J Clin Med Res. 2020 Feb;12(2):73-78. doi: 10.14740/jocmr4084. Epub 2020 Feb 1. J Clin Med Res. 2020. PMID: 32095176 Free PMC article. - A comparison of stool characteristics from normal and constipated people.
Aichbichler BW, Wenzl HH, Santa Ana CA, Porter JL, Schiller LR, Fordtran JS. Aichbichler BW, et al. Dig Dis Sci. 1998 Nov;43(11):2353-62. doi: 10.1023/a:1026699525487. Dig Dis Sci. 1998. PMID: 9824119 - Colonic fermentation of complex carbohydrates in patients with familial adenomatous polyposis.
Bradburn DM, Mathers JC, Gunn A, Burn J, Chapman PD, Johnston ID. Bradburn DM, et al. Gut. 1993 May;34(5):630-6. doi: 10.1136/gut.34.5.630. Gut. 1993. PMID: 8389311 Free PMC article. - Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation.
van Munster IP, Tangerman A, Nagengast FM. van Munster IP, et al. Dig Dis Sci. 1994 Apr;39(4):834-42. doi: 10.1007/BF02087431. Dig Dis Sci. 1994. PMID: 8149850
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical